BioLineRx BLRX
NASDAQ BLRX
$2.30 -0.06 (-2.54%)
As of: Sep 30, 2026 · 9:34 AM EDT

BioLineRx (BLRX) Minority Interest (2025 - 2026)

Updated

BioLineRx (BLRX) posted Minority Interest of $2.85 million for the quarter ended Jun 30, 2026, down 31.5% from the prior quarter.

Analysis

BioLineRx (BLRX) Minority Interest (2025 - 2026) Analysis & Trends

As of Dec 31, 2025, BioLineRx's Minority Interest came in at $5.15 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.85 Mn
Mar 31, 2026 4.16 Mn
Dec 31, 2025 5.15 Mn
API Access

BioLineRx Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=BLRX&period=max&api_key=YOUR_API_KEY